powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1972869477
Catherine Tang
Endocrinology
Boston,
MA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
537
Beneficiaries
—
Total drug cost
$212K
Distinct drugs
17
Brand share
62.2%
Top prescribed drugs
Levothyroxine Sodium
75 claims
Insulin Glargine,hum.Rec.Anlog
63 claims
Tirzepatide
41 claims
Alendronate Sodium
39 claims
Methimazole
33 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,547
Unique beneficiaries
—
Total services
17,822
Distinct HCPCS
30
Medicare payment
$222K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 341 Endocrinology providers in MA — top quintile (cohort median 496).